- RecruitingPHASE3
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
This study looks at new ways to treat a serious childhood cancer called neuroblastoma. It tests different treatment combinations, including chemotherapy and immunotherapy, to find the best approach for children with high-risk forms of the disease. The aim is to improve their chances of getting better.
For: NeuroblastomaAustralia · Austria · Belgium - Active not recruitingPHASE2
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
This study is looking into a new medicine called aldesleukin for children and young adults with newly diagnosed Type 1 diabetes. We want to see if it can help their bodies keep making their own insulin for longer, which could improve their health and make managing diabetes easier.
For: Type1 DiabetesUnited Kingdom - Recruiting
Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study
This study is checking on people who previously took part in the IVORY trial. It's looking at whether a low dose of a medicine called IL-2 helped reduce heart problems in people who had a heart attack, by lowering inflammation in their blood vessels.
For: Acute Coronary SyndromesUnited Kingdom